Intrathecal Actions of the Cannabis Constituents Δ(9)-Tetrahydrocannabinol and Cannabidiol in a Mouse Neuropathic Pain Model
(1) Background: The psychoactive and non-psychoactive constituents of cannabis, Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD), synergistically reduce allodynia in various animal models of neuropathic pain. Unfortunately, THC-containing drugs also produce substantial side-effects when administe...
Main Authors: | Sherelle L. Casey, Vanessa A. Mitchell, Eddy E. Sokolaj, Bryony L. Winters, Christopher W. Vaughan |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-08-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/23/15/8649 |
Similar Items
-
Combinations of Cannabidiol and Δ<sup>9</sup>-Tetrahydrocannabinol in Reducing Chemotherapeutic Induced Neuropathic Pain
by: Diana E. Sepulveda, et al.
Published: (2022-10-01) -
Plant-Based Cannabinoids for the Treatment of Chronic Neuropathic Pain
by: Sherelle L. Casey, et al.
Published: (2018-07-01) -
Cannabis, Cannabidiol Oils and Tetrahydrocannabinol—What Do Veterinarians Need to Know?
by: Nancy De Briyne, et al.
Published: (2021-03-01) -
Tetrahydrocannabinol and Cannabidiol for Pain Treatment—An Update on the Evidence
by: Kawthar Safi, et al.
Published: (2024-01-01) -
Medicinal cannabis for psychiatric disorders: a clinically-focused systematic review
by: Jerome Sarris, et al.
Published: (2020-01-01)